from Dreamers to Disruptors

The Challenges of Clinical Trial Digitization and The Digital Medicine Society (DiMe) Mission: Jennifer Goldsack

55 min · 11 de nov de 2025
Portada del episodio The Challenges of Clinical Trial Digitization and The Digital Medicine Society (DiMe) Mission: Jennifer Goldsack

Descripción

Jennifer Goldsack has made it her mission to push the boundaries of how technology can enhance healthcare. As founder and CEO of the Digital Medicine Society (DiMe), she supports digital innovators exploring new ways to deliver better outcomes for patients everywhere. Jennifer and Medidata CEO Anthony Costello explore how clinical trials once led the way in life sciences digitization, why they’re falling behind, and how we can get our industry back on track. Join them to discover how Jennifer is promoting innovation and making smarter use of clinical data, as well as her personal story of navigating the healthcare system and confronting the everyday challenges patients face. Visit our website [https://mdso.io/63cddc] Read our blog [https://mdso.io/ze1] Follow Medidata: LinkedIn [https://mdso.io/s7r], Instagram [https://mdso.io/rng], X [https://mdso.io/8du], YouTube [https://mdso.io/7rm] Follow Anthony: LinkedIn [https://mdso.io/mfp] Follow Jennifer: LinkedIn [https://mdso.io/37w3]

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de from Dreamers to Disruptors!

Empezar

2 meses por 1 €

Después 4,99 € / mes · Cancela cuando quieras.

  • Podcasts exclusivos
  • 20 horas de audiolibros / mes
  • Podcast gratuitos

Todos los episodios

13 episodios

Portada del episodio Medidata NEXT London 2026 LIVE

Medidata NEXT London 2026 LIVE

At its heart, Medidata NEXT is a conversation where leading experts in clinical research come together in open dialogue. Representing the biggest names in healthcare and life sciences from around the world, they explore industry challenges and share their excitement for what the future holds. That made NEXT Innovation Day London the perfect venue for our latest live edition of from Dreamers to Disruptors. Recorded straight from the show floor, Medidata leaders and a broad range of guests break down the power and incredible potential of AI across the clinical trial process, combining diverse perspectives into a united vision for the next era of healthcare technology. Session 1 Speakers: * Edward Ford | Vice President, Client Engagement, Medidata * Anthony Costello | CEO, Medidata * Nitish Mittal | Partner, Everest Group * Krzysztof Wróblewski | Head of Global Clinical Solutions Technologies, Senior Director, AstraZeneca Session 2 Speakers: * Aryana Hosseinkhani | Vice President, Head of Product Marketing, Medidata * Lisa Moneymaker | Chief Strategy Officer, Medidata * Chris Standley | Vice President, Vendor Governance, Worldwide Clinical Trials Session 3 Speakers: * Wayne Walker | GM, Head of Data Experience, Medidata * Robyn Orie | Sr. Director, Data Innovation, Caidya * Cassie Kendrew | Chief Operating Officer, EMS Healthcare * Amardeep Heer | Medidata Site Insights Board Member | Principal Investigator, Lakeside Healthcare Visit our website [https://mdso.io/63cddc] Read our blog [https://mdso.io/ze1] Follow Medidata: LinkedIn [https://mdso.io/s7r], Instagram [https://mdso.io/rng], X [https://mdso.io/8du], YouTube [https://mdso.io/7rm]

23 de jun de 202656 min
Portada del episodio Fighting Cancer with External Control Arms: Friends of Cancer Research’s Jeff Allen

Fighting Cancer with External Control Arms: Friends of Cancer Research’s Jeff Allen

External Control Arms are a powerful clinical research tool, harnessing cutting-edge tech to fill gaps in clinical data and accelerate trials when patients’ lives are on the line. They’re particularly valuable for cancer research, where patients can neither afford to wait nor settle for the current standard of care. Friends of Cancer Research President and CEO Jeff Allen sits down with Medidata CEO Anthony Costello and Senior Vice President, Statistics and Regulatory Science Innovation Ruthie Davi to celebrate 30 years of oncology innovation, and explore what’s coming next. They dig deep into Medidata and Friends’ partnership to bring the power of External Control Arms to pancreatic cancer research, and how to build a future where clinical research takes full advantage of these life-saving innovations. Visit our website [https://mdso.io/63cddc] Read our blog [https://mdso.io/ze1] Follow Medidata: LinkedIn [https://mdso.io/s7r], Instagram [https://mdso.io/rng], X [https://mdso.io/8du], YouTube [https://mdso.io/7rm] Follow Anthony: LinkedIn [https://mdso.io/mfp] Follow Jeff: LinkedIn [https://mdso.io/bvx] Follow Ruthie: LinkedIn [https://mdso.io/ryf]

26 de may de 202639 min
Portada del episodio Medidata NEXT New York 2026 LIVE

Medidata NEXT New York 2026 LIVE

NEXT New York is our flagship event, bringing together the world’s leading life sciences companies and thinkers to envision a transformative future for healthcare that challenges our preconceptions of what’s possible in clinical trials. This special edition of from Dreamers to Disruptors was recorded live from the show floor at NEXT, capturing the hottest takes and insights from Medidata leaders and special guests. From the end-to-end AI support reshaping studies, to building trust in cutting-edge clinical technologies, our speakers share their fresh perspectives on what matters most to pharma professionals today. Session 1 Speakers: * Edward Ford | Vice President, Client Engagement, Medidata * Anthony Costello | CEO, Medidata * Matteo di Tommaso | Senior Vice President, R&D Business Insights & Technology, Bristol Myers Squibb * Nimita Limaye | Research Vice President, Life Sciences R&D Strategy and Technology, IDC Session 2 Speakers: * Aryana Hosseinkhani | Vice President, Head of Product Marketing, Medidata * Meghan Harrington | Vice President, Clinical Trial Financial Management, Medidata * Paul O'Donohoe | Senior Director, eCOA Product and Science, Medidata * Sharlene Carnegie | Senior Vice President, Product and Engineering, Medidata Session 3 Speakers: * Jeff Ventimiglia | Senior Vice President, Offering and Portfolio Management, Medidata * Bryant Fields | Vice President, Partnerships, Medidata * Robert Lyons | Vice President, Engineering, Medidata * Jia Chen | Head, Product, AI, Medidata Session 4 Speakers: * Lisa Moneymaker | Senior Vice President, Chief Strategy Officer, Medidata * Tom Doyle | Senior Vice President, Chief Technology Officer, Medidata * Claire Biot | Vice President, Life Sciences and Healthcare Industry, Dassault Systèmes * Patrick Johnson | EVP, Corporate Research and Sciences, Dassault Systèmes Visit our website [https://mdso.io/63cddc] Read our blog [https://mdso.io/ze1] Follow Medidata: LinkedIn [https://mdso.io/s7r], Instagram [https://mdso.io/rng], X [https://mdso.io/8du], YouTube [https://mdso.io/7rm]

30 de mar de 20261 h 25 min
Portada del episodio Investing in the Future of Healthcare: 7wire Ventures’ Lee Shapiro

Investing in the Future of Healthcare: 7wire Ventures’ Lee Shapiro

As a veteran entrepreneur in life sciences, Lee Shapiro has invested in some of the most transformative technologies in modern healthcare history—developing a deep understanding of what makes for truly successful innovation. Medidata CEO Anthony Costello sits down with Lee to discover the secret to his success. Charting his work across a variety of leading life sciences organizations, from Allscripts and Livongo, to Click Therapeutics and Medidata itself, Lee uncovers the qualities that underpin the most accomplished enterprises. Join Lee and Anthony as they paint a powerful picture of our evolving industry and explore the disruptions shaping the future of healthcare. Visit our website [https://mdso.io/63cddc] Read our blog [https://mdso.io/ze1] Follow Medidata: LinkedIn [https://mdso.io/s7r], Instagram [https://mdso.io/rng], X [https://mdso.io/8du], YouTube [https://mdso.io/7rm] Follow Anthony: LinkedIn [https://mdso.io/mfp] Follow Lee: LinkedIn [https://mdso.io/4pa]

23 de feb de 20261 h 0 min
Portada del episodio Life Sciences Innovation in 2026: Predictions and Goals

Life Sciences Innovation in 2026: Predictions and Goals

As we enter the new year, the mandate is clear: evolve clinical research or get left behind. Join us to revisit conversations between Medidata CEO Anthony Costello and some of the leading industry minds—including Every Cure’s David Fajgenbaum, Digital Medicine Society’s Jennifer Goldsack, and Click Therapeutics’ David Klein—as they look to the future of life sciences in 2026 and beyond. From unlocking deeper data insights to scaling radical innovation, our guests issue a direct call to action: harness today’s cutting-edge technology to build a faster, smarter, and healthier world for patients everywhere. Visit our website [https://mdso.io/63cddc] Read our blog [https://mdso.io/ze1] Follow Medidata: LinkedIn [https://mdso.io/s7r], Instagram [https://mdso.io/rng], X [https://mdso.io/8du], YouTube [https://mdso.io/7rm] Follow Anthony: LinkedIn [https://mdso.io/mfp]

26 de ene de 202654 min